Management and support of patients with fibrosing interstitial lung diseases

被引:2
作者
Barbera, Tyonn [1 ]
Davila, Lesley [2 ]
Patel, Nina M. [3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Div Pulm & Crit Care Med, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75390 USA
[3] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York Presbyterian Hosp, Med, 630 W 168th St, New York, NY 10032 USA
关键词
fibrosing lung diseases; idiopathic pulmonary fibrosis; interstitial lung disease; lung fibrosis; patient education; progressive fibrosing interstitial lung disease; progressive fibrosing phenotype; IDIOPATHIC PULMONARY-FIBROSIS; DOUBLE-BLIND; CYCLOPHOSPHAMIDE; PIRFENIDONE; PLACEBO; CLASSIFICATION; AZATHIOPRINE; NINTEDANIB; MORTALITY; EFFICACY;
D O I
10.1097/01.NPR.0000743332.64602.aa
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Fibrosing interstitial lung diseases have a variable clinical course. Regular monitoring is important to assess disease progression and inform patient care and counseling. NPs play a key role in helping patients understand their disease and its treatment and manage the adverse reactions of pharmacologic therapies.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 51 条
[1]   Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test [J].
Andersen, Charlotte U. ;
Mellemkjaer, Soren ;
Hilberg, Ole ;
Nielsen-Kudsk, Jens Erik ;
Simonsen, Ulf ;
Bendstrup, Elisabeth .
RESPIRATORY MEDICINE, 2012, 106 (06) :875-882
[2]   Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians [J].
Bendstrup, Elisabeth ;
Moller, Janne ;
Kronborg-White, Sissel ;
Prior, Thomas Skovhus ;
Hyldgaard, Charlotte .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
[3]   A Survey of Glucocorticoid Adverse Effects and Benefits in Rheumatic Diseases: The Patient Perspective [J].
Black, Rachel J. ;
Goodman, Susan M. ;
Ruediger, Carlee ;
Lester, Susan ;
Mackie, Sarah L. ;
Hill, Catherine L. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (08) :416-420
[4]  
Brown KK, 2020, EUR RESPIR J, V55
[5]   Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report [J].
Collard, Harold R. ;
Ryerson, Christopher J. ;
Corte, Tamera J. ;
Jenkins, Gisli ;
Kondoh, Yasuhiro ;
Lederer, David J. ;
Lee, Joyce S. ;
Maher, Toby M. ;
Wells, Athol U. ;
Antoniou, Katerina M. ;
Behr, Juergen ;
Brown, Kevin K. ;
Cottin, Vincent ;
Flaherty, Kevin R. ;
Fukuoka, Junya ;
Hansell, David M. ;
Johkoh, Takeshi ;
Kaminski, Naftali ;
Kim, Dong Soon ;
Kolb, Martin ;
Lynch, David A. ;
Myers, Jeffrey L. ;
Raghu, Ganesh ;
Richeldi, Luca ;
Taniguchi, Hiroyuki ;
Martinez, Fernando J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (03) :265-275
[6]   Fibrosing interstitial lung diseases: knowns and unknowns [J].
Cottin, Vincent ;
Wollin, Lutz ;
Fischer, Aryeh ;
Quaresma, Manuel ;
Stowasser, Susanne ;
Harari, Sergio .
EUROPEAN RESPIRATORY REVIEW, 2019, 28 (151)
[7]   Population-based assessment of adverse events associated with long-term glucocorticoid use [J].
Curtis, Jeffrey R. ;
Westfall, Andrew O. ;
Allison, Jeroan ;
Bijlsma, Johannes W. ;
Freeman, Allison ;
George, Varghese ;
Kovac, Stacey H. ;
Spettell, Claire M. ;
Saag, Kenneth G. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (03) :420-426
[8]   Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study [J].
De Sadeleer, Laurens J. ;
Hermans, Frederik ;
De Dycker, Els ;
Yserbyt, Jonas ;
Verschakelen, Johny A. ;
Verbeken, Eric K. ;
Verleden, Geert M. ;
Verleden, Stijn E. ;
Wuyts, Wim A. .
EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (04)
[9]   Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study [J].
De Sadeleer, Laurens J. ;
Hermans, Frederik ;
De Dycker, Els ;
Yserbyt, Jonas ;
Verschakelen, Johny A. ;
Verbeken, Eric K. ;
Verleden, Geert M. ;
Wuyts, Wim A. .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
[10]   Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Distler, Oliver ;
Highland, Kristin B. ;
Gahlemann, Martina ;
Azuma, Arata ;
Fischer, Aryeh ;
Mayes, Maureen D. ;
Raghu, Ganesh ;
Sauter, Wiebke ;
Girard, Mannaig ;
Alves, Margarida ;
Clerisme-Beaty, Emmanuelle ;
Stowasser, Susanne ;
Tetzlaff, Kay ;
Kuwana, Masataka ;
Maher, Toby M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) :2518-2528